NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/23/2017
Back to search
Official data from USPTO
PHARMALEADS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
10/23/2017
Trademark type
Word
Nice classes
1
Filing date
10/28/2005
Registration date
10/09/2007
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/23/2017
Last transaction
10/23/2017
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
75013 Paris, FR
Examiner
TWOHIG, SHANNON MARIE
Law office
N30
Current location
TMO LAW OFFICE 121
Holders and representatives
Holders
PHARMALEADS
PHARMALEADS
Representatives
Dianne Smith-Misemer HOVEY WILLIAMS LLP
Technical classification
Nice Classes
Class 1
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals adapted for industrysciencesagriculturethe treatment of waters; diagnosis preparations adapted for scientific use; enzymesproteaseszinc metallopeptidasesphosphatiseskinases meant to be used in diagnosis preparations adapted for a scientificmedical or veterinary usefor research; enzymatic or cellular preparations adapted for industrial use; microorganism cultures other than the ones adapted for medical or veterinary use; chemicals for laboratory analysis other than the ones adapted for medical or veterinary use
Publications
History of USPTO decisions and trademark events.
35 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/23/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/23/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/23/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
09/26/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/09/2016
CORV
REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
07/31/2015
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/30/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/13/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/13/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/13/2013
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
08/30/2013
E815
TEAS SECTION 8 & 15 RECEIVED
08/30/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/16/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
10/09/2007
PUBO
PUBLISHED FOR OPPOSITION
07/24/2007
NPUB
NOTICE OF PUBLICATION
07/04/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/15/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/14/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/23/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/23/2007
ALIE
ASSIGNED TO LIE
05/23/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/07/2007
GNRT
NON-FINAL ACTION E-MAILED
11/06/2006
CNRT
NON-FINAL ACTION WRITTEN
11/06/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/25/2006
IROA
RESPONSE TO ITU OFFICE ACTION ENTERED
10/20/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/20/2006
GNRT
NON-FINAL ACTION E-MAILED
05/10/2006
CNRT
NON-FINAL ACTION WRITTEN
05/10/2006
DOCK
ASSIGNED TO EXAMINER
05/02/2006
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
04/07/2006
PAPER RECEIVED
04/07/2006
NWAP
NEW APPLICATION ENTERED
11/01/2005
Continuous trademark protection
Get notified about every new filing that threatens PHARMALEADS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.